Articles Archives - Page 562 of 701

MondayJul 08, 2019 11:20 am

Endonovo Therapeutics Inc. (ENDV) Offers Non-Narcotic, Non-Invasive Power of SofPulse to Help Patients Recover More Quickly

Proprietary bioelectronic devices developed by Endonovo Therapeutics target patient pain and inflammation while aiding wound recovery SofPulse® safely decreases pain by reducing edema (swelling), which decreases the need for prescription pain medications Endonovo’s wearable device can be used to address an array of medical conditions and is FDA-cleared for treating post-operative pain and edema in soft tissue Endonovo Therapeutics Inc. (OTCQB: ENDV) is transforming the field of medicine by developing safe, wearable, non-invasive bioelectric medical devices that deliver Endonovo’s Electroceutical™ Therapy. Targeting inflammatory conditions in vital organs and peripheral tissues, Endonovo’s SofPulse® is clinically proven to significantly speed the recovery…

MondayJul 08, 2019 10:46 am

Trxade Group Inc.’s (TRXD) Web Platform Promises Reduced Negative Reimbursement Costs for Pharmacies

Trxade hosts a S2P (supplier to pharmacy) pharmaceuticals trading platform Over 10,500 registered pharmacies are listed on Trxade’s platform The company achieved record first quarter 2019 financial results driven by an increase in revenues The proprietors of America’s independent pharmacies may well be cheering as the S2P (supplier to pharmacy) trading platform pioneered by Trxade Group Inc. (OTCQB: TRXD) swings into full gear, for its benefits extend to both trade and customers. The web-based platform not only identifies the best available prices for prescription drugs – a boon to patients – but helps pharmacists avoid negative reimbursement costs, which reduce…

MondayJul 08, 2019 10:08 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Leading the Way in Effective Cannabis Treatment

Lexaria developed and out-licenses DehydraTECH to create new (and improve existing) drug-delivery products The company is credited with leading the way forward in discovering new ways to effectively deliver CBD into the human body Lexaria is helping firms meet supply and demand requirements by creating products that offer lower dosing with higher absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is known for its innovative delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. The company developed drug-delivery platform DehydraTECH and out-licenses the platform to create new (and improve existing) orally ingested…

FridayJul 05, 2019 10:50 am

Spectrum Global Solutions Inc. (SGSI) Primed to Benefit as 5G Deployments Create Jobs, Safer Cities and Organic Growth Opportunities

SGSI is focused on creating and maintaining excellent customer relationships, along with providing proven value, quality, safety and reliability The company maintains high standards as it seeks out additional acquisitions SGSI is strategically positioned to meet rising demand for 5G, which offers the potential of creating three million jobs, safer cities and stronger economies Described as a leading single-source provider of end-to-end, next-gen telecommunications networks, Spectrum Global Solutions Inc. (OTCQB: SGSI) services reach across the United States, Canada, Puerto Rico, Guam and the Caribbean. The company’s end-to end offerings include bundled products of full-service engineering, construction, installation, maintenance and professional…

FridayJul 05, 2019 10:24 am

Green Hygienics Holdings Inc. (GRYN) Set to Benefit from New California Hemp Regulations Paving the Way for Widespread Cultivation

Legislative changes pertaining to hemp company registration in California are expected to enable widespread cultivation in the state Green Hygienics Holdings has already acquired a cultivation license in San Diego County to make full use of the growing California market The U.S. hemp industry is forecast to grow rapidly in the years to come; sales are anticipated to more than double in 2020, creating new business opportunities and a number of new jobs across various niches California is making progress in terms of enabling widespread commercial and industrial hemp cultivation. New industrial hemp regulations in the state establish registration procedures…

WednesdayJul 03, 2019 12:10 pm

Endonovo Therapeutics Inc. (ENDV) Appoints National Leader in Pain Management to Scientific Advisory Board

Appointment of Dr. Steven Levin of Johns Hopkins University to Endonovo’s scientific advisory board is expected to help facilitate the introduction of Endonovo’s non-invasive bio-electrical medical devices to hospitals and clinics The global wearable medical devices market is expected to grow to nearly $67 billion by 2026 at a CAGR of 26.1 percent Endonovo holds 27 patents and numerous trademarks for several proprietary technologies and medical devices Endonovo Therapeutics Inc. (OTCQB: ENDV), a commercial-stage developer of non-invasive electroceutical therapeutic devices, has appointed Dr. Steven Levin, M.D., a national leader in the field of pain management, to its scientific advisory board. Levin…

WednesdayJul 03, 2019 10:54 am

Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Closes Initial Share Purchase of Cannova Medical Ltd.

Nabis Holdings has closed on its previously announced initial purchase of a 49 percent interest in Cannova Medical Ltd., with an option to purchase the remaining 51 percent The company selected Cannova Medical for its unique approach to consumable cannabis technology and untapped industry potential Nabis sees Cannova as a potential disruptor in the edible cannabis industry Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company pursuing specialty investment opportunities in the burgeoning cannabis industry (among others), recently announced that it has now completed the purchase of a 49 percent interest in Cannova Medical Ltd.,…

WednesdayJul 03, 2019 10:11 am

Trxade Group Inc.’s (TRXD) Fiscal 2019 Off to Record Start with Q1 Revenue of $1.5 Million

TRXD sales grew to $1.5 million in Q1 2019; operating income also rose when compared to the same period of the prior year The company is adding new independent pharmacies and increasing pharmacy sales Mail-order pharmacy services and a newly launched mobile app offer lower prescription drug costs for U.S. consumers Trxade Group Inc. (OTCQB: TRXD), an integrated pharmaceutical logistical services company that offers a web-based e-hub buying platform for transactions between independent pharmacists and drug manufacturers, reported record Q1 2019 revenues. The company also reported (http://ibn.fm/3NJq6) higher operating income, as it sees “continuing revenue growth and profitability in 2019.” TRXD…

TuesdayJul 02, 2019 11:15 am

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Readies for Canada’s Second Cannabis Wave with Successful Run of APP Extraction Process

Sproutly is a licensed producer with exclusive rights to Infusion Biosciences’ groundbreaking Aqueous Phytorecovery Process (“APP”) technology for naturally water-soluble cannabinoids Deloitte estimates that Canada’s cannabis edibles and topicals market could be worth $2.7 billion annually The company has entered into an exclusive joint venture with Moosehead Breweries Limited to develop and produce nonalcoholic, cannabis-infused beverages Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) has reached another milestone by successfully completing the first run of the proprietary Aqueous Phytorecovery Process (“APP”) extraction technology licensed from Infusion Biosciences Inc., Sproutly CEO and Director Keith Dolo announced in a news release (http://ibn.fm/JJ0Yt).…

TuesdayJul 02, 2019 10:20 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Enhanced DehydraTECH Delivers More CBD into the Body

The new version of the DehydraTECH delivery platform is suitable for use in pills, capsules and tablets for the pharmaceutical, medical and supplement markets DehydraTECH has demonstrated that it can deliver eight times more CBD into the blood than standard industry formulations Animal testing shows that combining DehydraTECH with a nanoemulsion formulation greatly assists delivery of cannabinoids and nicotine across the blood-brain barrier Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) new enhanced version of its patented delivery technology, DehydraTECH, has demonstrated that it can deliver eight-times more CBD into the blood and 19-times more CBD into the brain tissue than…

Site Search

Company Search

Category: Articles